Wednesday, Nov. 18, 2026 · about a 5-minute read
Good morning. Yesterday a daily Alzheimer's pill came back a win for some patients in a 1,535-person trial, Waymo sent its robotaxis to Alaska to learn ice and darkness, a fusion company said it has the cash for its last two physics tests, and lab-grown human livers caught 10 drugs that animal tests missed. Today, the brain implants giving people who lost their voice a melody again.
The big one
People Who Lost Their Voice Could Sing Again. A Brain Implant Just Carried a Tune. At the Society for Neuroscience's annual meeting, three teams showed brain implants that give back more than words. A UC Davis team's brain-driven synthetic voice carries pitch, which made speech easier to understand and let one participant sing. A Massachusetts General Hospital team reported a person with no voluntary movement at all who has talked independently through an implant for more than a year. And a Georgia Tech and Emory team ran brain-to-text on an iPhone. Each is a single patient in a conference talk, not yet peer reviewed.
Why it matters: a voice is more than words, and an implant that carries tone, jokes and song gives back the part of speech that makes people sound like themselves. Our odds on when a fully implanted speech device is approved are below the line. Read it →
Yesterday on the site
The End of Disease
A Daily Pill May Slow Alzheimer's for Some People, a 1,535-Person Trial Finds: AriBio's AR1001 missed its main goal across all 1,535 patients but met it in the 604 not already taking other Alzheimer's pills, where it slowed decline by about 31%, the company says (topline release, not yet published).
Safer Pills Ahead? Lab-Grown Livers Caught All 10 Drugs That Fooled Animal Tests, Maker Says: VivoSim says its lab-grown human liver tissue flagged all 10 drugs that passed animal safety tests and then harmed people's livers in trials (company claim; a look-back test, not peer reviewed).
Lose Fat, Keep the Grip: A Daily Pill Spared Muscle on Weight-Loss Drugs in Mice: Onconic's OCN-501 pill, taken with a semaglutide-type drug, kept more muscle and grip strength in obese mice (in mice; secondary report of company data).
Robots & Self-Driving
Robotaxis That Can Handle Winter? Waymo Sends Its Cars to Alaska to Learn Ice and Darkness: Waymo test cars, with a specialist at the wheel and no fares, are on Fairbanks streets learning ice fog and buried lane lines (secondary report; no service date).
Every Chatbot Upgrade Could Make Robots Smarter, So OpenAI Folded Its Robot Team: OpenAI dissolved its standalone robotics team, betting its general models can run robots directly; in an Nvidia simulation its GPT-6 Astra finished about 3 in 4 pick-and-place tasks, against about 1 in 2 for the best dedicated robot model (secondary report).
Robots Safe Enough to Live With Us: LG Signs Up for Korea's New Safety Test: LG agreed Nov. 13 to help build South Korea's humanoid safety certification and to seek a pilot certificate for the two-legged robot it plans to unveil in early 2027 (secondary report).
Walking Robots Need Tougher Hands to Build Cars. China's Carmakers Just Pulled Them Off the Line.: Geely, XPeng and Li Auto are scaling back factory humanoids: too slow for a fast line, hands that wear out, and plain robot arms that do the job cheaper (Caixin investigation, secondary report).
To the Stars
Rockets Could Carry Their Own AI Data Centers Into Orbit. India Signs a Factory Deal.: Indian launch startup Agnikul agreed to build a ₹510 crore (5.1 billion rupee) plant making data-center units for its rockets' top stage, with NeevCloud as its first customer (secondary report).
Limitless Energy
Day-and-Night Clean Power: A Fusion Machine Now Has the Cash to Chase 100 Million Degrees: General Fusion says $140.9 million in cash, with no debt, funds its LM26 machine through 2028 for its last two tests: 100 million degrees, then net-energy physics (company claims).
By the numbers
604: patients not already on Alzheimer's pills, the group where the daily pill AR1001 met its goal.
10 of 10: drugs that fooled animal tests and then harmed human livers, all flagged by lab-grown liver tissue, its maker says.
$140.9 million: General Fusion's cash, which it says carries its test machine through 2028.
About 3 in 4: simulated robot tasks OpenAI's general model finished, against about 1 in 2 for the best dedicated robot model.
New on the odds board
Yesterday's posts put fresh odds on a daily Alzheimer's pill being approved in the U.S., Waymo opening public rides in snowy Toronto, General Fusion's machine reaching 100 million degrees, a general AI model running a real robot arm with no robot training, lab-grown liver tests replacing animal liver studies, a humanoid earning Korea's new safety certificate, a muscle-sparing pill for weight-loss drugs being approved, humanoids keeping pace on a car line in regular use, and an Agnikul rocket carrying an AI computing module into orbit. The whole board lives on the calculator.
On the calendar
December 2026: Nvidia's promised code release for its GR00T 2 robot model.
Fourth quarter of 2026: VivoSim's first joint programs testing AI-designed compounds on its lab-grown livers are expected to begin, the first forward-looking test.
First quarter of 2027: LG unveils its two-legged humanoid.
2027: OpenAI's target for a first public demo of its own humanoid robot.
Third quarter of 2027: the extension of the AR1001 Alzheimer's trial finishes, giving a second year of data.
By the end of 2028: the runway General Fusion says covers its last two physics tests.
The story we're following
Robots that live with us. Yesterday brought three steps at once: OpenAI bet that the same general models behind its chatbot can run robots directly, LG signed up to help write South Korea's safety test for humanoids that share a home with children and older parents, and China's carmakers named exactly what today's humanoids still can't do on a fast line, from keeping pace to keeping their hands in working order. Read it →
Quote of the day
"The best way to predict the future is to invent it." — Alan Kay, the computer scientist, who says he first used the line in 1971 at a meeting of Xerox PARC researchers and Xerox planners, as traced by Quote Investigator. This week the inventing is happening in brain implants that sing, livers grown in a dish and robots being taught to share a home.
Coming up
Already up this morning: brain implants that give people who lost their voice a melody again. Later today: at 9 AM, Google's DNA-reading AI now spots nearly twice as many gene switches; at 10 AM, a robot friend for lonely care-home residents gets $30 million behind it; at 11 AM, seven lasers face off against drones in the Utah desert.
Until next time
That's today in the future. If someone you know would want to wake up to this, forward it to them, and if you're reading a forward, subscribe here. It's free every morning.



